The interaction of E-selectin with CD44 expressed by LS174T colon carcinoma cells was originally hypothesized based on CD44 immunoreactivity with the HECA-452 antibody, which detects sialofucosylated oligosaccharides (a group to which E-selectin binds) [20]. Here, SELE is linked to colon carcinoma.